Ozempic itself only comes as an injection, but the same active ingredient, semaglutide, is available in pill form under the brand name Rybelsus. Both medications are made by the same manufacturer, Novo Nordisk, and work the same way in your body. The key difference is that Rybelsus is currently approved only for type 2 diabetes, not for weight loss.
Rybelsus: The Pill Version of Semaglutide
Semaglutide is the drug behind three brand names: Ozempic (a weekly injection for type 2 diabetes), Wegovy (a weekly injection for weight loss), and Rybelsus (a daily pill for type 2 diabetes). Rybelsus is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events like heart attack and stroke in diabetic adults at high risk.
If you’re looking for a semaglutide pill specifically for weight loss, that option doesn’t exist yet as an approved product. Rybelsus is sometimes prescribed off-label for weight management, but it comes in lower doses than what’s been studied for significant fat loss.
Why a Semaglutide Pill Is Tricky to Make
Semaglutide is a protein-based molecule, and proteins normally get broken down by stomach acid before they can reach the bloodstream. Rybelsus solves this with a special absorption enhancer called SNAC, a compound that shields semaglutide from digestive enzymes and helps it pass through the stomach lining intact. This technology is the reason the pill has such strict rules about how you take it.
Even with this technology, the pill version delivers less semaglutide into your bloodstream compared to the injection. The doses aren’t interchangeable on a milligram-to-milligram basis. Someone switching from a 0.5 mg Ozempic injection would move to either a 7 mg or 14 mg Rybelsus tablet, illustrating how much more of the oral dose is needed to achieve a similar effect.
How to Take the Pill
Rybelsus has unusually specific instructions that directly affect how well the drug works. You need to take it first thing in the morning on an empty stomach, at least 30 minutes before eating, drinking anything other than water, or taking any other medications. You swallow the tablet whole with no more than 4 ounces of plain water.
These rules aren’t just suggestions. Eating or drinking too soon reduces absorption and weakens the drug’s effect. Waiting longer than 30 minutes before eating can actually increase absorption. Crushing or chewing the tablet also interferes with how it’s designed to work.
The dosing schedule starts at 3 mg daily for the first 30 days, which is purely a ramp-up phase that doesn’t provide blood sugar benefit on its own. After that, the dose increases to 7 mg daily. If more blood sugar control is needed after another 30 days, it can go up to 14 mg, the highest currently available strength.
Side Effects Compared to the Injection
The pill and the injection share the same core side effects because they contain the same drug. Both commonly cause nausea, vomiting, diarrhea, constipation, abdominal pain, and acid reflux. Rybelsus may also cause loss of appetite, burping, and gas. Most of these are gastrointestinal and tend to be worst during dose increases, then ease over time.
Neither form has a clearly better side effect profile than the other. The choice between pill and injection usually comes down to whether you prefer a daily pill with strict timing rules or a once-weekly injection with more flexibility around meals.
Cost of the Pill vs. the Injection
At list price, Rybelsus and Ozempic cost the same: about $936 per month. Actual out-of-pocket costs depend heavily on your insurance plan, since manufacturers offer rebates and coupons that can lower the price significantly. Private insurance coverage varies by plan. Medicare currently cannot cover weight loss drugs, and Medicaid coverage differs by state.
If you’re considering Rybelsus specifically to avoid the cost of Ozempic, the sticker price alone won’t save you money. Your insurance formulary, copay structure, and any manufacturer savings programs are what determine which option is actually cheaper for you.
A Higher-Dose Weight Loss Pill Is in Development
Novo Nordisk has been testing a 50 mg oral semaglutide tablet specifically for weight loss in people without diabetes. In a completed phase 3 trial published in The Lancet, participants taking the 50 mg pill lost an average of 15.1% of their body weight over 68 weeks, compared to 2.4% with a placebo. More than half of participants on the pill lost at least 15% of their body weight, and about a third lost 20% or more.
Those results are in the same ballpark as injectable Wegovy, which would make this the first oral semaglutide option that rivals the injection for weight loss. Gastrointestinal side effects were common, affecting 80% of participants on the 50 mg dose, though most were mild to moderate. This higher-dose pill has not yet been approved by the FDA, so it’s not available for prescriptions.
For now, if you want semaglutide in pill form, Rybelsus at 3, 7, or 14 mg is the only option on the market, and it carries a diabetes indication rather than a weight loss one. The injectable versions remain the standard for people using semaglutide primarily to lose weight.